GL

Financials

Globe Life

Price Chart

Market Data

Financials

XBRL · SEC EDGAR

2014–2025(12yr)

Revenue

Net Income

Metric	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025Latest	YoY
Revenue	$4.0B	$3.8B	$3.9B	$4.2B	$4.3B	$4.5B	$4.7B	$5.1B	$5.2B	$5.4B	$5.8B	$6.0B	+3.7%
Net Income	$542.9M	$527.1M	$549.8M	$1.5B	$701.5M	$760.8M	$731.8M	$745.0M	$739.7M	$970.8M	$1.1B	$1.2B	+8.4%
Net Margin	13.7%	14.0%	14.0%	35.0%	16.3%	16.8%	15.4%	14.6%	14.2%	17.8%	18.5%	19.4%	+0.8pp
ROA	2.69%	2.65%	2.56%	6.20%	3.04%	2.93%	2.52%	2.50%	2.90%	3.46%	3.68%	3.77%	+0.1pp
EPS (Diluted)	$4.09	$4.16	$4.49	$12.22	$6.09	$6.83	$6.82	$7.22	$7.47	$10.07	$11.94	$14.07	+17.8%

Total Debt$2.3B

Cash & Equiv.$61.7M

Net Debt$2.3B

3 min read

1. THE BIG PICTURE

Globe Life operates a highly efficient insurance engine that targets the lower-middle-income market with a cost structure its larger rivals cannot match. By maintaining lower administrative expenses than its peers, it converts a higher percentage of premiums into profit, allowing it to return massive amounts of capital to shareholders even while maintaining a smaller revenue footprint than industry giants.

2. WHERE THE RISKS HIT HARDEST

Globe Life’s primary competitive advantage—its low-cost operating model—is directly threatened by ongoing litigation and EEOC scrutiny regarding the classification of its independent sales agents (10-K Item 1A). If forced to reclassify these agents as employees, the "lower policy acquisition and administrative expense levels" that management cites as its edge would likely evaporate under the weight of increased benefits and payroll costs (10-K Item 1). Furthermore, while Globe Life relies on its exclusive agency force for "sustainable growth," this creates a structural vulnerability where any disruption in agent recruitment or retention immediately stalls sales (14A Proxy, 10-Q).

3. WHAT THE NUMBERS SAY TOGETHER

The data reveals a company that is prioritizing capital efficiency over raw scale. While Globe Life is significantly smaller by revenue than peers like MetLife or Prudential, its 20.2% net margin and 23.0% ROTCEROTCEReturn on Tangible Common Equity — the primary profitability measure for bank investors; net income as a percent of tangible equity. Higher is better lead the peer group (XBRL, Peer Benchmarking). This profitability supports a massive 11.2% buyback yield, the highest among its peers. Recent results show a divergence in product momentum: while life insurance premiums grew a steady 3%, health insurance net sales surged 71% in the most recent quarter (8-K). This suggests that supplemental health products are currently driving the growth narrative more than the core life business, which saw a more modest 11% increase in net sales (8-K).

4. IS IT WORTH IT AT THIS PRICE?

At 8.7x forward earnings, Globe Life trades at a modest discount to the peer median of 9.5x. At this multiple, the market is pricing in a long-term growth rate of approximately 0.5% (CAPM analysis). This appears cautious given that Globe Life grew TTMTTMTrailing Twelve Months — the most recent full year of financial data, updated on a rolling basis each quarter revenue by 3.7% and saw double-digit net sales growth in several divisions last quarter (8-K, XBRL). The discount is likely a reflection of the "Elevated" risk surrounding agent litigation; investors are essentially demanding a higher yield to compensate for the possibility of a structural shift in the labor model. If growth were to track GDP at 2.5%, the sensitivity analysis suggests a justified multiple of 22.2x, indicating significant upside if regulatory fears subside (CAPM analysis).

5. WHAT WOULD CHANGE THIS VIEW?

Cautious if any court ruling or regulatory action mandates the reclassification of independent agents, as this would structurally impair Globe Life's margin advantage (10-K Item 1A).
Constructive if the American Income Life Division shows a sustained acceleration in agent headcount, which management identifies as the primary driver of sales growth (10-Q).
Cautious if the health underwriting margin, which recently grew 9%, begins to compress due to rising medical costs or regulatory pressure on Medicare Supplement rates (8-K, 10-K Item 1).

6. BOTTOM LINE

Structural Advantage: A low-cost, exclusive distribution network that generates industry-leading margins from the underserved middle-income demographic. Bottom Line: Globe Life is a highly profitable cash-return machine whose valuation is currently capped by a binary regulatory risk regarding its workforce.

Source: Synthesis · LLM Analysis

3 min read

1. Top 5 Material Risks

Independent Contractor Classification: Globe Life faces ongoing litigation and regulatory scrutiny, including a September 2024 EEOC determination regarding specific agents, which could force the reclassification of agents as employees, significantly increasing operating costs (10-K Item 1A).
Liquidity Dependency on Subsidiaries: As a holding company, Globe Life relies on dividends from insurance subsidiaries to pay debt obligations and corporate expenses; these dividends are restricted by state statutory requirements and solvency thresholds (10-K Item 1A).
Investment Portfolio Credit and Market Risk: The portfolio consists primarily of fixed-income investments; significant interest rate volatility or credit defaults could lead to realized losses and a reduction in shareholders’ equity (10-K Item 1A).
Third-Party Vendor Reliance: Globe Life utilizes third-party vendors for critical business functions, exposing Globe Life to operational failures, data breaches, or service disruptions that could lower revenues and increase costs (10-K Item 1A).
Catastrophic Mortality Risk: As a life and health insurer, Globe Life is exposed to catastrophic events such as pandemics or natural disasters, which could cause substantial volatility in financial results and increase policy obligations (10-K Item 1A).

2. Company-Specific Risks

Short Selling Campaigns: Globe Life has been the target of short sellers publishing reports that caused significant declines in the common stock price, damaged reputation, and necessitated the expenditure of significant resources to defend against resulting class action and derivative litigation (10-K Item 1A).
Niche Market Concentration: Globe Life focuses on specific niches including labor unions and affinity groups; deterioration in these relationships or negative public receptivity to direct-to-consumer marketing could negatively affect the life insurance business (10-K Item 1A).
Alternative Investment Volatility: Globe Life has increased its allocation to alternative investments like limited partnerships, which are more volatile and illiquid than fixed-income securities and may not meet regulatory admissibility requirements for capital (10-K Item 1A).
FHLB Funding Concentration: Globe Life relies on institutional funding agreements from the Federal Home Loan Bank (FHLB); changes in collateral definitions or eligibility requirements could force Globe Life to seek alternative, potentially more expensive, funding sources (10-K Item 1A).

3. Regulatory/Legal Risks

Medicare Supplement Rate Regulation: Profitability in the Medicare Supplement business depends on the timely approval of premium rate increases by state regulators to offset health care inflation; failure to obtain these approvals could adversely impact profitability (10-K Item 1A).
Reinsurance Structure Capital Efficiency: Under a 2025 intercompany reinsurance agreement, Globe Life ceded approximately $1.2 billion of life statutory reserves to GL Re; future regulatory changes by the Bermuda Monetary Authority could require the holding company to contribute additional capital to recapture this business (10-K Item 1A).
Privacy and Data Security Compliance: Globe Life is subject to federal and state privacy laws, including HIPAA and GLBA; non-compliance by Globe Life or its third-party business associates could result in material fines, penalties, and adverse actions against business licenses (10-K Item 1A).

4. Financial Impact Map

Independent Contractor Reclassification → Operating Costs → Potential for significant increase if agents are reclassified as employees. Liquidity Dependency on Subsidiaries → Cash Flow / Dividends → Impairments in subsidiary assets or operations could disallow dividend payments to the parent company. Investment Portfolio Credit/Market Risk → Shareholders’ Equity → Significant unrealized losses from fixed-income declines could substantially reduce capital position. Catastrophic Mortality Risk → Profit Margins / Income → Increased policy obligations and claims could materially reduce profitability. Medicare Supplement Rate Regulation → Profitability → Inability to secure timely premium increases could adversely impact the margins of the supplemental health insurance business.

Source: 10-K Item 1A · LLM Analysis

Recent Filings

Form	Filed	Period
10-K	Feb 2026	Dec 2025
8-K	Feb 2026	—
10-Q	Nov 2025	Sep 2025
14A	Mar 2025	—